Chiesi, Lundbeck and Li-Cor Biosciences scored exits as the oncology therapy developer floated in an upsized $75.6m initial public offering.

Advance Publications and American Express scored exits as the fashion subscription service floated at the top of its range in an upsized offering.

AES and Siemens' energy storage venture, which also counts Qatar Investment Authority as an investor, priced the offering above its range.

The Ntwrk and Cox Enterprises-backed lifestyle and media platform developer is joining forces with B Riley Principal 150 Merger Corp at an approximate valuation of $1bn.

Roc Nation-backed healthy restaurant chain Sweetgreen plans to float on the New York Stock Exchange having reportedly raised about $630m in funding.

Takeda, Merck & Co, Ipsen and Merck Group all scored exits as the immuno-oncology drug developer floated at the bottom of its IPO range.

The market communicationns platform developer is going public today in an $81m initial public offering which will enable OpenText to exit.

AstraZeneca, Eli Lilly and Sinopharm all achieved exits as the cancer therapy developer listed on the Hong Kong Stock Exchange at a reported valuation of nearly $1.1bn.

The cancer immunotherapy developer, which counts Novo and Lundbeck as investors, filed to raise up to $100m in its initial public offering.

The Real Web-backed automotive marketing software developer intends to use the IPO proceeds to accelerate the development of new products, fuel its M&A strategy and expand its customer base.